This site is intended for health professionals only!

Published on 10 July 2007

Share this story:
Twitter
LinkedIn
Share
RELATED ARTICLES
Bausch + Lomb initiates phase III program for glaucoma drug
Newly published data demonstrate sustained efficacy and safety profile of biosimilar infliximab in RA
Positive opinion for PARP 1/2 inhibitor in Europe
New Forum and recommendations for diabetes injection technique launched in Ireland
Conference focuses on the future of pharmacy

COPD drug access widened

teaser

European regulators have expanded the number of patients eligible for treatment with GlaxoSmithKline’s chronic obstructive pulmonary disorder drug Seretide



Most read

1
Feedback: Automation systems in your hospital
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
Janssen-Cilag’s Stelara approved by NICE
4
Merck agrees huge Vioxx settlement
5
Encouraging results for SLE treatment



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:
Twitter
LinkedIn
Share
RELATED ARTICLES
RPSGB calls for “greater sense of urgency”
Sitagliptin approved as add-on to insulin
Communication – the name of the game
Drug information training in hepatic disease
Results show MRI benefits of Rebif